Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 24, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abcellera Biologics Inc.
| 83.33K |
$0.19 | $15,666.79 | +4.08% | 2.12M |
Jun 21
| |||||||
Abcellera Biologics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 14
| |||||||
Abcellera Biologics Inc.
| 20K |
$5.19 | $103,800.00 | +0.99% | 2.04M |
Sep 12
| |||||||
Abcellera Biologics Inc.
| 250K |
$0.19 | $47,500.00 | +14.12% | 2.02M |
May 5
| |||||||
Abcellera Biologics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 1
| |||||||
Abcellera Biologics Inc.
| 200K |
$6.34 | $1,267,780.00 | +12.74% | 1.77M |
May 16
| |||||||
Abcellera Biologics Inc.
| 230.79K |
$8.66 | $1,998,632.74 | +17.23% | 1.57M |
Feb 28
| |||||||
Abcellera Biologics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 7
| |||||||
Abcellera Biologics Inc.
| 250K |
$0.19 | $47,500.00 | +18.67% | 1.59M |
Dec 8
| |||||||
Abcellera Biologics Inc.
| 83.33K |
$0.19 | $15,833.27 | +6.22% | 1.42M |
Nov 30
| |||||||
Abcellera Biologics Inc.
| 83.33K |
$14.96 | $1,246,661.68 | +6.22% | 1.42M |
Nov 30
| |||||||
Abcellera Biologics Inc.
| 333.33K |
$0.19 | $63,333.27 | +33.13% | 1.34M |
Jun 15
| |||||||
Abcellera Biologics Inc.
| -1.00M |
$25.50 | -$25,500,000.00 | -78.52% | 273.63K |
Jun 9
| |||||||
Abcellera Biologics Inc.
| 23K |
$20.00 | $460,000.00 | +2.20% | 1.07M |
Oct 29 - Dec 15
| |||||||
Abcellera Biologics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||